Shahzad Malik
InvestorGeneral Partner at Advent Life Sciences
London
Writes $25K β $5M checks Β· typically $1M
About
Shahzad Malik joined Advent in 1999 with a background in science, clinical medicine, and international finance. He holds an MA in Physiological Sciences from Oxford University and an MD from Cambridge University, and previously specialised in interventional cardiology while conducting research on heart muscle disorders. At Advent he has worked with over 30 life sciences portfolio companies across Europe and the USA.
Invests in
Biotech
Experience
- Advent Life Sciences LLPGeneral Partnercurrent1999 β present
- MQ: Transforming Mental HealthChair Of The Board Of Trusteescurrent2019 β present
- McKinsey & CompanyAssociate1997 β 1999
- NHSInterventional Cardiologist1991 β 1997
Education
- University of CambridgeMB,BChir, Medicine1988 β 1990
- University of OxfordMA, Medicine1985 β 1988
Skills & more
Venture Capital61Private Equity17Start-ups23Growth Capital33Entrepreneurship12Mergers3Corporate Development31Lifesciences10Biotechnology12Valuation8Commercialization7Investor Relations7
+12 more
Emerging MarketsIPOMedical DevicesBoard of DirectorsJoint VenturesCapital RaisingAngel InvestingDeal SourcingStrategyBusiness DevelopmentIntellectual PropertyDue DiligenceFrom Shahzad's professional profile.
Same school
Also attended University of Cambridge621
Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures
+ 615 more
Also attended University of Oxford687
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 681 more
Shared employers
Also worked at McKinsey & Company1,127
Jim BreyerFounder & CEO of Breyer CapitalAnn Miura-KoCo-founding Partner at FloodgateJeremy LiewPartner at Lightspeed Venture PartnersMike SpeiserManaging Director at Sutter Hill VenturesJeremy LevinePartner at Bessemer Venture PartnersFabrice GrindaCo-founder & Managing Partner at FJ Labs
+ 1,121 more
Deals Β· 1
MoximedBoard seat
via Advent Life Sciences Β· filed Aug 2024 Β· $91M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Advent Life Sciences
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Dominic Schmidt
General Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Gail Jermyn
Investor Relations Partner at Advent Life Sciences

.png)










.jpg)













